(Q71756049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1 reference

coronary artery disease

1 reference

J Ruiz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

H Blanché

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R W James

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M C Garin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

C Vaisse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Charpentier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

N Cohen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Morabia

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Passa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Froguel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

869-872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

8979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-CIII gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Lipoproteins and atherogenesis. Current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Calculation of attributable risks from epidemiological data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Lipid peroxide levels of serum lipoprotein fractions of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992709-3

7 January 2021

10.1016/S0140-6736(95)92709-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7564671%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference